目录
- Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon
- Interpretation of Chinese expert consensus on the whole-course management of hepatocellular carcinoma (2023 edition)
- Associations between physical activity and risk of liver cancer: results from a population-based cohort study in Chinese women
- Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma
- Precise staging of advanced HCC promotes higher quality of personalized treatment management:Chinese experts consensus on precision diagnosis and management of advanced hepatocellular carcinoma (2023)
- Introduction of the Chinese expert consensus on postoperative adjuvant therapy for hepatocellular carcinoma (2023 Edition)
- Racial, ethnic, and socioeconomic differences in hepatocellular carcinoma across the United States